Recommended by myself as a Strong Buy at 8.00-9.00 pence on 15.10.04
http://www.iqep.com/
Daily Execution Price and Volume






(USA)

Semi Index

!FUNDAMENTALS!NEWS
Preliminary Full Year Results - Tue 22 Mar 2005
IQE plc was formed in May 1999 by the merger of two leading wafer foundries, each with a proven track record in the supply of high quality electronic and optoelectronic materials produced using MBE and MOCVD platforms. We believe that the expertise and experience across a diverse range of materials available from IQE is unparalleled within the compound semiconductor industry.
LATEST NEWS :
RNS Number:8494E
IQE PLC
04 November 2004
IQE secures major outsourcing contract with leading RF component manufacturer
IQE's North American subsidiary, IQE Inc, today announced it has secured a major
outsourcing contract to supply a leading North American RF Component
Manufacturer with epitaxial materials for its RF based components used in mobile
handsets. The agreement, which is effective from 1st November 2004 and is for a
minimum term of two years, renewable annually thereafter, provides for IQE's
Bethlehem site to supply more than 90% of the customer's anticipated demand for
their advanced RF wafer products and is estimated to be worth around US$25
million in revenue to IQE over the initial two year period. As a result of the
agreement, internal wafer manufacture at the customer's site will cease. Both
parties have been working closely together for several years; a relationship
through which IQE has gained a high degree of confidence in its own ability to
service the outsourced epiwafer needs of major manufacturers.
IQE's President & CEO, Drew Nelson said "This agreement with such a prominent
global supplier of RF components for the cellular phone market demonstrates a
clear movement towards the outsourcing model within the compound semiconductor
industry. Their selection of IQE as the primary partner, as a result of our
large and comprehensive production capacity, and low cost structure, endorses
the Company's commitment to the outsource model"
A spokesman for the customer commented: "outsourcing certain products and
services such as the manufacture of our RF epitaxial wafers allow us to
concentrate our efforts on the processes that add significant value to our
product offering within the global, highly competitive RF market place and we
are pleased to build on previous work we have undertaken with IQE. This
agreement will allow us to be one of the most highly cost effective players in
the RF component marketplace"
Tradeshows
IQE actively participates in a wide range of tradeshows, conferences and seminars throughout the World.
IQE will be participating in the following forthcoming trade event:
--------------------------------------------------------------------------------
EVENT LOCATION DATE
--------------------------------------------------------------------------------IEDM 2004 San Francisco, CA 07 Dec 2004

(05 November 2004)
The Company was notified today by Canada Life Limited, that following the
purchase of 2,000,000 ordinary shares of 1 pence each in the Company ("Ordinary
Shares") at 11.6 pence each, Canada Life Marketing Group is now interested in
14,551,156 Ordinary Shares. These Ordinary Shares represent 4.6 per cent. of the
issued share capital of the Company.
(20 October 2004) Scottish Widows Investment Partnership Ltd on
behalf of Lloyds TSB Group plc and its subsidiary companies, that they are
interested in 24,020,662 ordinary shares of 1 pence each in the Company
("Ordinary Shares"). Of this interest, 22,039,762 Ordinary Shares are material
interests, which represent 6.98 per cent of the Company's current issued share
capital.
Director Holdings :
Dr Drew Nelson 26,724,636 (5 Nov 2003)
Dr Michael Scott 26,157,970 (5 Nov 2003)
Martin Lamb 3,775,584 (5 Nov 2003)
Dr Godfrey Ainsworth 1,627,020 (20 Oct 2004).
Buy Note published by House Broker Evolution Beeson Gregory on 04.11.04 :
Evolution Securities 100 Wood Street, London, EC2V 7AN 020 7071 4300
Evolution
SECURITIES
www.evosecurities.com 4 November 2004
IQE (IQE) Buy
Mkt cap: 36m Net cash: 11m Contract win Price/Target: 11p/15p
Breakthrough contract win
IQE has announced that it has won a $25m two year outsourcing deal
with a leading US RF component manufacturer. This is a genuine
breakthrough for IQE it gives us the confidence needed to raise our
target price to 15p
IQE have won a major outsourcing contract with a leading US Radio Frequency
wireless/mobile components company. The contract has a minimum term of
two years and an initial value of $25m. This is one of the four contracts that
management were referring to at the time of the fund raising in November
2004. The other three do not appear to be close to signing at present but the
list of potential customers is still there and management continue to talk to
other parties. This contract win proves that there is a market for wholesale
outsourcing of epitaxy and we expect others to follow but not in the
immediate future.
We estimate the split to be $10m:$15m between year one and year two. The
contract involves the closure of the customer's facilities and because of the
sensitive nature of this the identity of the customer has not been announced.
We are not changing our forecasts. This $10m for the first year is already in our
27.2m revenues estimate for next year. It is worth noting that because the
contract is with an existing customer there is an element of revenue substitution
in this contract. However, this announcement does mean that we are
considerably more comfortable with the forecasts than we were.
If more contracts come through, the revenues should go straight into our
forecasts. We would not expect the other contracts to be as substantial as this
but given the marginal loss/profit scenario we have forecast for next year their
effect on earnings could be significant.
As a result of this announcement we have increased confidence in the forecasts
and so we are increasing our share price target to 15p.
Ian Robertson +44 (0)20 7071 4463 ian.robertson@evosecurities.com EVO Securities is broker to IQE
Year end Sales (m) EBITDA (m) PTP (m) EPS (p) PER (x) Yield (%) EV/Sales (x) Revised?
12/03A 18.8 -11.3 -12.8 -6.2 - - 1.3
12/04E 17.1 -8.3 -9.9 -3.1 - - 1.5 No
12/05E 27.2 0.4 -1.5 -0.5 - - 0.9
21. 75 1 5/1 0/03 LOW 2 .20 11/ 3/0 3 LAST 8 .50 Source: DATASTREAM